Literature DB >> 20646909

Exercise-induced left ventricular systolic dysfunction in women heterozygous for dystrophinopathy.

Robert M Weiss1, Richard E Kerber, Jane K Jones, Carrie M Stephan, Christina J Trout, Paul D Lindower, Kimberly S Staffey, Kevin P Campbell, Katherine D Mathews.   

Abstract

BACKGROUND: Mutations in the X-linked gene encoding dystrophin cause skeletal and cardiac muscle diseases in men. Female "carriers" also can develop overt disease. The purpose of this study was to ascertain the prevalence of cardiac contractile abnormalities in dystrophinopathy carriers.
METHODS: Twenty-four dystrophinopathy heterozygotes and 24 normal women each underwent standard exercise stress echocardiography.
RESULTS: Heterozygotes demonstrated mildly lower left ventricular ejection fractions (LVEFs) at rest compared with controls (0.56 + or - 0.10 vs 0.62 + or - 0.07, P = .02). After exercise, the mean LVEF fell to 0.53 + or - 0.14 in heterozygotes but rose to 0.73 + or - 0.07 in controls (P < .001). Twenty-one of 24 dystrophinopathy heterozygotes demonstrated > or = 1 of the following: abnormal resting LVEF, abnormal LVEF response to exercise, or exercise-induced wall motion abnormality.
CONCLUSIONS: Women heterozygous for dystrophinopathy demonstrate significant left ventricular systolic dysfunction, which is unmasked by exercise. This finding has mechanistic implications for both inherited and acquired cardiac disease states. Copyright 2010 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646909      PMCID: PMC3156088          DOI: 10.1016/j.echo.2010.05.007

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  32 in total

1.  Complexity in simplicity: monogenic disorders and complex cardiomyopathies.

Authors:  J Chen; K R Chien
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

2.  Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy.

Authors:  R Ortiz-Lopez; H Li; J Su; V Goytia; J A Towbin
Journal:  Circulation       Date:  1997-05-20       Impact factor: 29.690

3.  Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study.

Authors:  E M Hoogerwaard; E Bakker; P F Ippel; J C Oosterwijk; D F Majoor-Krakauer; N J Leschot; A J Van Essen; H G Brunner; P A van der Wouw; A A Wilde; M de Visser
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

4.  Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

Authors:  C Badorff; G H Lee; B J Lamphear; M E Martone; K P Campbell; R E Rhoads; K U Knowlton
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

5.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

6.  Diastolic myocardial mechanics in hypertrophic cardiomyopathy.

Authors:  Shemy Carasso; Hua Yang; Anna Woo; Michal Jamorski; E Douglas Wigle; Harry Rakowski
Journal:  J Am Soc Echocardiogr       Date:  2010-02       Impact factor: 5.251

7.  X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes.

Authors:  J Azofeifa; T Voit; C Hübner; M Cremer
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

8.  Altered dystrophin expression in the right atrium of a patient after Fontan procedure with atrial flutter.

Authors:  C J McMahon; M Vatta; C D Fraser; J A Towbin; A C Chang
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

9.  Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.

Authors:  R Coral-Vazquez; R D Cohn; S A Moore; J A Hill; R M Weiss; R L Davisson; V Straub; R Barresi; D Bansal; R F Hrstka; R Williamson; K P Campbell
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

10.  Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies.

Authors:  L Politano; V Nigro; G Nigro; V R Petretta; L Passamano; S Papparella; S Di Somma; L I Comi
Journal:  JAMA       Date:  1996-05-01       Impact factor: 56.272

View more
  1 in total

Review 1.  Cardiac involvement in Duchenne and Becker muscular dystrophy.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Antigoni Papavasiliou; Genovefa Kolovou
Journal:  World J Cardiol       Date:  2015-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.